Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2004-06-30
2010-11-23
Wehbe, Anne Marie S (Department: 1633)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388210, C530S388800
Reexamination Certificate
active
07838637
ABSTRACT:
The present invention relates to a single-chain, multiple antigen-binding molecule with diverse variable domains of a heavy and of a light chain of an immunoglobulin, which are connected in the form of a VH-VL construct, which are in turn connected together via a peptide, and to the preparation and use thereof as pharmaceutical or diagnostic aid.
REFERENCES:
patent: 5830880 (1998-11-01), Sedlacek et al.
patent: 5851527 (1998-12-01), Hansen
patent: 5854019 (1998-12-01), Sedlacek et al.
patent: 5885833 (1999-03-01), Mueller et al.
patent: 5916803 (1999-06-01), Sedlacek et al.
patent: 7507796 (2009-03-01), Little et al.
patent: 196 17 851 (1997-11-01), None
patent: 196 39 103 (1998-03-01), None
patent: 197 04 301 (1998-03-01), None
patent: 196 49 645 (1998-04-01), None
patent: 196 51 443 (1998-06-01), None
patent: 197 10 643 (1998-09-01), None
patent: 0610046 (1994-10-01), None
patent: 0 790 313 (1997-08-01), None
patent: 0 860 445 (1998-08-01), None
patent: WO 93/06217 (1993-04-01), None
patent: WO 93/11161 (1993-10-01), None
patent: WO 96/06943 (1996-03-01), None
Mack et al. (1995) Proc. Natl. Acad. Sci., vol. 92, 7021-7025.
Gruber et al. (1994) J. Immunol., vol. 152, 536-5374.
Kurucz et al. (1995) J. Immunol., vol. 154, 4576-4582.
Pluckthun and Pack (1997) Immunotechnology, vol. 3, 83-105.
Holliger et al. (1996) Protein Engineering, vol. 9 (3), 299-305.
De Jonge et al. (1995) Molecular Immunology, vol. 32, No. 17/18, 1405-1412.
Deonarain et al. (1998) Exp. Opin. Ther. Patents, vol. 8 (1), 53-69.
Miller et al. (1995) FASEB, vol. 9, 190-199.
De Jonge, J. et al. (1995) “Production and Characterization of Bispecific Single-Chain Antibody Fragments”Molecular Immunology32(17/18):1405-1412.
Baltazar Becerril et al., “Toward Selection of Internalizing Antibodies from Phage Libraries”Biochemical and Biophysical Research Communications(1999), No. 255, pp. 386-393. Academic Press.
Biocca et al., “Intracellular Immunization: Antibody Targeting to Subcellular Compartments”Trends in Cell Biology(1995), vol. 5:248-253.
Deonarain et al., “Targeting Enzymes for Cancer Therapy: Old Enzymes in New Roles”Br. J. Cancer(1994), 70:786-794.
Deonarain M., “Ligand-Targeted Receptor-Mediated Vectors for Gene Delivery”Exp. Opin. Ther. Patents(1998), 8(1):53-69.
Douglas, Joanne T. et al., “Targeted Gene Delivery by Tropism-Modified Adenoviral Vectors”Nature Biotechnology(1996), 14:1574-1578.
Dubel, Stefan et al., “Isolation of IgG Antibody Fv-DNA From Various Mouse and Rat Hybridoma Cell Lines Using the Polymerase Chain Reaction with a Simple Set of Primers”J. Immunological Methods(1994), No. 175, pp. 89-95. Elsevier Science B.V.
Ellis, “Vaccine Development: Progression From Target Antigen to Product”Genetically Engineered Vaccines(1992), pp. 263-271.
Fanger et al., “Bispecific Antibodies”Critical Review in Immunology(1992), 12(3,4):101-124.
Fitzgerald et al., “Improved Tumor Targeting by Disulphide Stabilized Diabodies Expressed in Pichia Pastoris”,Protein Engineering(1997), 10(10):1221-1225.
Glockshuber et al., “A Comparison of Strategies to Stabilized Immunoglobulin Fv—Fragments”Biochemistry(1990), 29:1362-1367.
Gottschalk S. et al., “A Novel DNA-Peptide Complex for Efficient Gene Transfer and Expression in Mammalian Cells”Gene Therapy(1996), No. 3, pp. 448-457. Stockton Press.
Gruber, Meegan et al., “Efficient Tumor Cell Lysis Mediated by a Bispecific Single Chain Antibody Expressed inEscherichia coli” The Journal of immunology(1994), 152:5368-5374. The American Association of Immunologists.
Harris et al., “Gene Therapy for Cancer Using Tumour-Specific Prodrug Activation”Gene Therapy(1994), 1:170-175.
Hawkins et al., “A Genetic Approach to Idiotypic Vaccination”Journal of Immunotherapy(1993), 14:273-278.
Hayden et al., “Single-Chain Mono and Bispecific Antibody Derivatives With Novel Biological Properties and Antitumour Activity From a COS Cell Transient Expression System”,Therapeutic Immunology(1994), 1:3-15.
Hochuli et al., “Genetic Approach to Facilitate Purification of Recombinant Proteins With a Novel Metal Chelate Absorbent”Biotechnology(1988), pp. 1321-1325.
Holliger et al., “Engineering Bispecific Antibodies”Current Opinion in Biotechnology(1993), 4:446-449.
Holliger et al., “Retargeting Serum Immunoglobulin With Bispecific Diabodies”Nature Biotechnology(1997), 15:632-636.
Holliger et al., “Diabodies: Small Bivalent and Bispecific Antibody Fragments”Proc. Natl. Acad. Sci. U.S.A. (1993), 90:6444-6448.
Holliger et al., “Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody”,Protein Engin. (1996), 9(3):299-305.
Jan De Jonge et al., “Production and Characterization of Bispecific Single-Chain Antibody Fragments”Molecular Immunology(1995), 32(17,18):1405-1412. Pergamon.
Jang, Y.J. et al., “The Structural Basis for DNA Binding by an Anti-DNA Autoanitbody”Molecular Immunology(1998), No. 35, pp. 1207-1217. Elsevier Science Ltd.
John De Kruif et al., “Selection and Application of Human Single Chain Fv Antibody Fragments From a Semi-synthetic Phage Antibody Display Library with Designed CDR3 Regions”J. Mol. Biol. (1995), No. 248, pp. 97-105. Academic Press Limited.
Jones et al., “Replacing the Comlementarity-Determining Regions in a Human Antibody With Those From a Mouse”Nature(1986), 321:523-525.
Klivenyl, Gabor et al., “Gallium-68 Chelate Imaging of Human Colon Carcinoma Xenografts Pretargeted With Bispecific Anti-CD44v6/Anti-Gallium Chelate Antibodies”J. Nucl. Med. (1998), No. 39, pp. 1769-1776.
Kontermann et al., “Complement Recruitment Using Bispecific Diabodies”Nature Biotechnology(1997), vol. 15.
Kontermann et al., “Enzyme Immunoessays Using Bispecific Diabodies”Immunotechnology(1997), 3:137-144.
Krebber, Anke et al., “Reliable Cloning of Functional Antibody Variable Domains From Hybridomas and Spleen Cell Repertoires Employing a Reengineered Phage Display System”J. Immunological Methods(1997), No. 201, pp. 35-55. Elsvier Science B.V.
Krebs et al., “Recombinant Human Single Chain FvAntibodies Recognizing Human Interleuikin-6”The Journal of Biological Chemistry(1998), pp. 2858-2865.
Kurucz, Istvan et al., “Retargeting of CTL by an Efficiently Refolded Bispecific Single-Chain FV Dimer Produced in Bacteria”The Journal of Immunology(1995), 154:4576-4582.
Lesley, Jayne et al., “Modulation of Transferrin Receptor Expression and Function by Anti-Transfeerin Receptor Antibodies and Antibody Fragments”Experimental Cell Research(1989), No. 182, pp. 215-233. Academic Press, Inc.
Liu, He et al., “Constitutive and Antibody-Induced Internalization of Prostate-Specific Membrane Antigen”Cancer Research(1998), No. 58, pp. 4055-4060.
Lucibello et al., “Periodic cdc25C Transcription is Mediated by a Novel Cell Cycle-Regulated Repressor Element (CDE)”The EMBO Journal(1995), 14:132-142.
Mack, Matthias et al., “A Small Bispecific Antibody Construct Expressed as a Functional Single-Chain Molcule With High Tumor Cell Cytotoxity”Proc. Natl. Acad. Sci. USA (1995), 92:7021-7025.
Mallender et al., “Construction, Expression, and Activity of a bivalent Bispecific Single-Chain Antibody”The Journal of Biological Chemistry(1994), 269:199-206.
McCartney et al., “Engineering Disulfied-linked Single-chain FvDimers [(sFv′)2] With Improved Solution and Targeting Properties: Anti-Digoxin 26-10 (sFv′)2and anti-c-erbB-2 741F8 (sFv′)2Made by Protein Folding and Bonded Through C-terminal Cysteinyl Peptides”Protein Engineering(1994), 8(3):301-314.
Miller N. et al., Targeted vectors for gene therapy (1995), FASEB Journal 9, 190-099.
Milstein et al., “Hybrid Hybrid
Kontermann Roland
Mueller Rolf
Sedlacek Hans-Harald
Affitech Research AS
Saliwanchik Lloyd & Saliwanchik
Wehbe Anne Marie S
LandOfFree
Single-chain multiple antigen-binding molecule, its... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Single-chain multiple antigen-binding molecule, its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single-chain multiple antigen-binding molecule, its... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4233038